1. FRI0128 Integrated safety data analysis across phase 3 clinical studies for intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. (12th June 2018) Authors: Husni, M.E.; Schwartzman, S.; Deodhar, A.; Kafka, S.; Chakravarty, S.D.; Hsia, E.C.; Harrison, D.D.; Leu, J.H.; Zhou, Y.; Lo, K.H.; Kavanaugh, A. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 608 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗